nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—HRH1—atherosclerosis	0.512	1	CbGaD
Epinastine—CYP2B6—Simvastatin—atherosclerosis	0.0517	0.15	CbGbCtD
Epinastine—CYP2D6—Niacin—atherosclerosis	0.0316	0.0915	CbGbCtD
Epinastine—ABCB1—Ezetimibe—atherosclerosis	0.0285	0.0826	CbGbCtD
Epinastine—ABCB1—Simvastatin—atherosclerosis	0.0265	0.0768	CbGbCtD
Epinastine—ABCB1—Lovastatin—atherosclerosis	0.0259	0.0751	CbGbCtD
Epinastine—ABCB1—Pravastatin—atherosclerosis	0.0259	0.0751	CbGbCtD
Epinastine—CYP2D6—Simvastatin—atherosclerosis	0.025	0.0724	CbGbCtD
Epinastine—CYP2D6—Lovastatin—atherosclerosis	0.0244	0.0708	CbGbCtD
Epinastine—CYP2D6—Pravastatin—atherosclerosis	0.0244	0.0708	CbGbCtD
Epinastine—CYP3A4—Ezetimibe—atherosclerosis	0.0171	0.0495	CbGbCtD
Epinastine—CYP3A4—Rosuvastatin—atherosclerosis	0.0171	0.0495	CbGbCtD
Epinastine—CYP3A4—Simvastatin—atherosclerosis	0.0159	0.046	CbGbCtD
Epinastine—CYP3A4—Lovastatin—atherosclerosis	0.0155	0.045	CbGbCtD
Epinastine—CYP3A4—Pravastatin—atherosclerosis	0.0155	0.045	CbGbCtD
Epinastine—HTR2A—arteriole—atherosclerosis	0.00402	0.138	CbGeAlD
Epinastine—HTR7—vein—atherosclerosis	0.00385	0.132	CbGeAlD
Epinastine—Cough increased—Rosuvastatin—atherosclerosis	0.00269	0.0727	CcSEcCtD
Epinastine—Eye irritation—Lovastatin—atherosclerosis	0.00245	0.0661	CcSEcCtD
Epinastine—HTR2A—vein—atherosclerosis	0.0024	0.0823	CbGeAlD
Epinastine—Cough increased—Niacin—atherosclerosis	0.00196	0.0529	CcSEcCtD
Epinastine—HTR2A—hindlimb—atherosclerosis	0.00159	0.0547	CbGeAlD
Epinastine—HTR7—artery—atherosclerosis	0.00157	0.0538	CbGeAlD
Epinastine—Phenindamine—HRH1—atherosclerosis	0.00139	0.29	CrCbGaD
Epinastine—HTR2A—appendage—atherosclerosis	0.00137	0.0469	CbGeAlD
Epinastine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00133	0.0359	CcSEcCtD
Epinastine—HTR7—endothelium—atherosclerosis	0.00132	0.0454	CbGeAlD
Epinastine—Sinusitis—Rosuvastatin—atherosclerosis	0.00129	0.0349	CcSEcCtD
Epinastine—Rhinitis—Rosuvastatin—atherosclerosis	0.00124	0.0335	CcSEcCtD
Epinastine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00123	0.0332	CcSEcCtD
Epinastine—HTR7—blood vessel—atherosclerosis	0.00122	0.0419	CbGeAlD
Epinastine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.0012	0.0323	CcSEcCtD
Epinastine—Nasopharyngitis—Pravastatin—atherosclerosis	0.00115	0.031	CcSEcCtD
Epinastine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00114	0.0308	CcSEcCtD
Epinastine—Sinusitis—Lovastatin—atherosclerosis	0.0011	0.0296	CcSEcCtD
Epinastine—Sinusitis—Ezetimibe—atherosclerosis	0.00108	0.029	CcSEcCtD
Epinastine—HRH2—cardiovascular system—atherosclerosis	0.00107	0.0367	CbGeAlD
Epinastine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00103	0.0278	CcSEcCtD
Epinastine—Sinusitis—Simvastatin—atherosclerosis	0.00103	0.0277	CcSEcCtD
Epinastine—Pharyngitis—Ezetimibe—atherosclerosis	0.00102	0.0276	CcSEcCtD
Epinastine—HTR2A—artery—atherosclerosis	0.000977	0.0335	CbGeAlD
Epinastine—Cough—Rosuvastatin—atherosclerosis	0.000941	0.0254	CcSEcCtD
Epinastine—Methdilazine—HRH1—atherosclerosis	0.00094	0.196	CrCbGaD
Epinastine—Sinusitis—Pravastatin—atherosclerosis	0.000927	0.025	CcSEcCtD
Epinastine—Rhinitis—Niacin—atherosclerosis	0.000904	0.0244	CcSEcCtD
Epinastine—Rhinitis—Pravastatin—atherosclerosis	0.00089	0.024	CcSEcCtD
Epinastine—Pharyngitis—Pravastatin—atherosclerosis	0.000881	0.0238	CcSEcCtD
Epinastine—Infection—Rosuvastatin—atherosclerosis	0.000874	0.0236	CcSEcCtD
Epinastine—HTR2A—endothelium—atherosclerosis	0.000825	0.0283	CbGeAlD
Epinastine—Cough—Ezetimibe—atherosclerosis	0.000782	0.0211	CcSEcCtD
Epinastine—HTR2A—blood vessel—atherosclerosis	0.000761	0.0261	CbGeAlD
Epinastine—Infection—Lovastatin—atherosclerosis	0.000741	0.02	CcSEcCtD
Epinastine—Infection—Ezetimibe—atherosclerosis	0.000727	0.0196	CcSEcCtD
Epinastine—Infection—Simvastatin—atherosclerosis	0.000693	0.0187	CcSEcCtD
Epinastine—Cough—Niacin—atherosclerosis	0.000685	0.0185	CcSEcCtD
Epinastine—Cough—Pravastatin—atherosclerosis	0.000674	0.0182	CcSEcCtD
Epinastine—HRH2—liver—atherosclerosis	0.000662	0.0227	CbGeAlD
Epinastine—Infection—Pravastatin—atherosclerosis	0.000626	0.0169	CcSEcCtD
Epinastine—HTR7—connective tissue—atherosclerosis	0.000626	0.0215	CbGeAlD
Epinastine—Pruritus—Rosuvastatin—atherosclerosis	0.000622	0.0168	CcSEcCtD
Epinastine—Headache—Rosuvastatin—atherosclerosis	0.000551	0.0149	CcSEcCtD
Epinastine—HTR7—cardiovascular system—atherosclerosis	0.000545	0.0187	CbGeAlD
Epinastine—Pruritus—Lovastatin—atherosclerosis	0.000528	0.0142	CcSEcCtD
Epinastine—ADRA1A—cardiovascular system—atherosclerosis	0.000525	0.018	CbGeAlD
Epinastine—Pruritus—Ezetimibe—atherosclerosis	0.000517	0.014	CcSEcCtD
Epinastine—ABCB1—blood vessel—atherosclerosis	0.000499	0.0171	CbGeAlD
Epinastine—Mirtazapine—HRH1—atherosclerosis	0.000494	0.103	CrCbGaD
Epinastine—Pruritus—Simvastatin—atherosclerosis	0.000493	0.0133	CcSEcCtD
Epinastine—HRH1—connective tissue—atherosclerosis	0.000467	0.016	CbGeAlD
Epinastine—Headache—Lovastatin—atherosclerosis	0.000467	0.0126	CcSEcCtD
Epinastine—ADRA1A—adipose tissue—atherosclerosis	0.000463	0.0159	CbGeAlD
Epinastine—ADRA2A—connective tissue—atherosclerosis	0.000459	0.0157	CbGeAlD
Epinastine—Headache—Ezetimibe—atherosclerosis	0.000458	0.0124	CcSEcCtD
Epinastine—Pruritus—Niacin—atherosclerosis	0.000453	0.0122	CcSEcCtD
Epinastine—Pruritus—Pravastatin—atherosclerosis	0.000446	0.012	CcSEcCtD
Epinastine—Headache—Simvastatin—atherosclerosis	0.000437	0.0118	CcSEcCtD
Epinastine—CYP2B6—cardiovascular system—atherosclerosis	0.000416	0.0143	CbGeAlD
Epinastine—Headache—Niacin—atherosclerosis	0.000401	0.0108	CcSEcCtD
Epinastine—Headache—Pravastatin—atherosclerosis	0.000395	0.0107	CcSEcCtD
Epinastine—HTR2A—connective tissue—atherosclerosis	0.00039	0.0134	CbGeAlD
Epinastine—Mianserin—HRH1—atherosclerosis	0.000363	0.0756	CrCbGaD
Epinastine—HRH1—adipose tissue—atherosclerosis	0.000359	0.0123	CbGeAlD
Epinastine—ADRA2A—adipose tissue—atherosclerosis	0.000352	0.0121	CbGeAlD
Epinastine—HTR2A—cardiovascular system—atherosclerosis	0.00034	0.0116	CbGeAlD
Epinastine—HTR7—liver—atherosclerosis	0.000337	0.0116	CbGeAlD
Epinastine—ADRA1A—liver—atherosclerosis	0.000325	0.0111	CbGeAlD
Epinastine—Nortriptyline—HRH1—atherosclerosis	0.000324	0.0676	CrCbGaD
Epinastine—Trimipramine—HRH1—atherosclerosis	0.000305	0.0637	CrCbGaD
Epinastine—Desipramine—HRH1—atherosclerosis	0.000267	0.0557	CrCbGaD
Epinastine—CYP2B6—liver—atherosclerosis	0.000257	0.00883	CbGeAlD
Epinastine—Imipramine—HRH1—atherosclerosis	0.000226	0.0472	CrCbGaD
Epinastine—Amitriptyline—HRH1—atherosclerosis	0.000225	0.0469	CrCbGaD
Epinastine—ABCB1—cardiovascular system—atherosclerosis	0.000223	0.00763	CbGeAlD
Epinastine—HTR2A—liver—atherosclerosis	0.00021	0.0072	CbGeAlD
Epinastine—ABCB1—adipose tissue—atherosclerosis	0.000196	0.00673	CbGeAlD
Epinastine—CYP3A4—liver—atherosclerosis	0.000194	0.00667	CbGeAlD
Epinastine—CYP2D6—liver—atherosclerosis	0.000191	0.00656	CbGeAlD
Epinastine—ABCB1—liver—atherosclerosis	0.000138	0.00472	CbGeAlD
Epinastine—Oxcarbazepine—ALB—atherosclerosis	0.000133	0.0278	CrCbGaD
Epinastine—Nortriptyline—ALB—atherosclerosis	7.49e-05	0.0156	CrCbGaD
Epinastine—Amitriptyline—ALB—atherosclerosis	5.19e-05	0.0108	CrCbGaD
Epinastine—HTR7—Signaling Pathways—NOS3—atherosclerosis	7.54e-06	0.000104	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—MTHFR—atherosclerosis	7.53e-06	0.000104	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	7.53e-06	0.000104	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	7.48e-06	0.000103	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	7.46e-06	0.000103	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CD36—atherosclerosis	7.45e-06	0.000103	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARA—atherosclerosis	7.39e-06	0.000102	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ABCA1—atherosclerosis	7.37e-06	0.000102	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LPA—atherosclerosis	7.35e-06	0.000101	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	7.33e-06	0.000101	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	7.32e-06	0.000101	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SPP1—atherosclerosis	7.28e-06	0.0001	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SPP1—atherosclerosis	7.27e-06	0.0001	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	7.26e-06	0.0001	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	7.25e-06	9.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	7.23e-06	9.97e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	7.21e-06	9.94e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AGT—atherosclerosis	7.16e-06	9.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	7.15e-06	9.86e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	7.13e-06	9.83e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—BGN—atherosclerosis	7.12e-06	9.82e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	7.1e-06	9.79e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—VEGFA—atherosclerosis	7.09e-06	9.78e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—MTHFR—atherosclerosis	7.06e-06	9.73e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOA5—atherosclerosis	7.05e-06	9.72e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—STAT3—atherosclerosis	7.02e-06	9.68e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—APOE—atherosclerosis	7.01e-06	9.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	6.99e-06	9.64e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CAV1—atherosclerosis	6.95e-06	9.58e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.95e-06	9.58e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—APOA1—atherosclerosis	6.93e-06	9.56e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARA—atherosclerosis	6.93e-06	9.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	6.8e-06	9.38e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.78e-06	9.35e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	6.74e-06	9.29e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	6.72e-06	9.27e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AGT—atherosclerosis	6.71e-06	9.25e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MAPK3—atherosclerosis	6.71e-06	9.25e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL8—atherosclerosis	6.69e-06	9.22e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	6.63e-06	9.13e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	6.6e-06	9.09e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	6.6e-06	9.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AGT—atherosclerosis	6.58e-06	9.07e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOE—atherosclerosis	6.57e-06	9.06e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AGT—atherosclerosis	6.56e-06	9.05e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.55e-06	9.03e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CAV1—atherosclerosis	6.51e-06	8.98e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TGFB1—atherosclerosis	6.51e-06	8.97e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOA1—atherosclerosis	6.5e-06	8.96e-05	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—AKT1—atherosclerosis	6.46e-06	8.91e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—LEP—atherosclerosis	6.44e-06	8.88e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOE—atherosclerosis	6.44e-06	8.88e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	6.44e-06	8.88e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—LEP—atherosclerosis	6.43e-06	8.87e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOE—atherosclerosis	6.43e-06	8.87e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CAV1—atherosclerosis	6.39e-06	8.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CAV1—atherosclerosis	6.37e-06	8.78e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOA1—atherosclerosis	6.37e-06	8.78e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL6—atherosclerosis	6.36e-06	8.77e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOA1—atherosclerosis	6.36e-06	8.76e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	6.33e-06	8.72e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—HMOX1—atherosclerosis	6.32e-06	8.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	6.31e-06	8.7e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	6.31e-06	8.7e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	6.25e-06	8.62e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	6.24e-06	8.6e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ESR1—atherosclerosis	6.15e-06	8.48e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ESR1—atherosclerosis	6.14e-06	8.46e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	6.13e-06	8.45e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARG—atherosclerosis	6.11e-06	8.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—F2—atherosclerosis	6.08e-06	8.38e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—F2—atherosclerosis	6.06e-06	8.36e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOB—atherosclerosis	6.06e-06	8.35e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—atherosclerosis	6.05e-06	8.34e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	6.02e-06	8.31e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—INS—atherosclerosis	5.99e-06	8.26e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NFKB1—atherosclerosis	5.99e-06	8.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	5.98e-06	8.25e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.96e-06	8.22e-05	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—AKT1—atherosclerosis	5.96e-06	8.21e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—F2—atherosclerosis	5.95e-06	8.2e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	5.93e-06	8.18e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTM1—atherosclerosis	5.89e-06	8.12e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK8—atherosclerosis	5.88e-06	8.11e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.88e-06	8.1e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—AKT1—atherosclerosis	5.87e-06	8.09e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	5.86e-06	8.08e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	5.86e-06	8.08e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LIPC—atherosclerosis	5.84e-06	8.05e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	5.82e-06	8.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	5.81e-06	8.01e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOC3—atherosclerosis	5.8e-06	8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	5.8e-06	8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	5.8e-06	7.99e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—LPL—atherosclerosis	5.78e-06	7.97e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LDLR—atherosclerosis	5.77e-06	7.95e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARG—atherosclerosis	5.73e-06	7.89e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOB—atherosclerosis	5.71e-06	7.87e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	5.7e-06	7.85e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GPX1—atherosclerosis	5.64e-06	7.78e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CETP—atherosclerosis	5.63e-06	7.77e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—INS—atherosclerosis	5.62e-06	7.74e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	5.6e-06	7.72e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	5.57e-06	7.68e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	5.56e-06	7.66e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.55e-06	7.66e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—F2—atherosclerosis	5.53e-06	7.62e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—INS—atherosclerosis	5.51e-06	7.59e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CD36—atherosclerosis	5.5e-06	7.58e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—INS—atherosclerosis	5.49e-06	7.57e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—atherosclerosis	5.49e-06	7.57e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	5.45e-06	7.52e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—LPL—atherosclerosis	5.45e-06	7.51e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—atherosclerosis	5.43e-06	7.49e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	5.42e-06	7.47e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL2—atherosclerosis	5.41e-06	7.45e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.4e-06	7.44e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—INS—atherosclerosis	5.39e-06	7.43e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—atherosclerosis	5.38e-06	7.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	5.33e-06	7.34e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GPX1—atherosclerosis	5.32e-06	7.33e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF1—atherosclerosis	5.31e-06	7.33e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	5.3e-06	7.31e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	5.29e-06	7.29e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NOS3—atherosclerosis	5.25e-06	7.24e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	5.21e-06	7.19e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—atherosclerosis	5.21e-06	7.18e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CD36—atherosclerosis	5.18e-06	7.14e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—atherosclerosis	5.15e-06	7.1e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK3—atherosclerosis	5.14e-06	7.09e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARA—atherosclerosis	5.11e-06	7.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.1e-06	7.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	5.07e-06	6.99e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	5.06e-06	6.97e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	5.05e-06	6.96e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—INS—atherosclerosis	5.01e-06	6.91e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—atherosclerosis	4.99e-06	6.87e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	4.95e-06	6.83e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AGT—atherosclerosis	4.95e-06	6.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	4.93e-06	6.79e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NOS3—atherosclerosis	4.93e-06	6.79e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.91e-06	6.77e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—atherosclerosis	4.91e-06	6.76e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOE—atherosclerosis	4.85e-06	6.68e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	4.84e-06	6.68e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	4.83e-06	6.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.82e-06	6.64e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARA—atherosclerosis	4.82e-06	6.64e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—atherosclerosis	4.8e-06	6.62e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CAV1—atherosclerosis	4.8e-06	6.62e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOA1—atherosclerosis	4.79e-06	6.61e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	4.73e-06	6.52e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AGT—atherosclerosis	4.66e-06	6.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	4.6e-06	6.34e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOE—atherosclerosis	4.57e-06	6.3e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.54e-06	6.26e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CAV1—atherosclerosis	4.53e-06	6.24e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—atherosclerosis	4.53e-06	6.24e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOA1—atherosclerosis	4.52e-06	6.23e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—atherosclerosis	4.5e-06	6.21e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	4.39e-06	6.06e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.38e-06	6.03e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	4.28e-06	5.9e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	4.27e-06	5.89e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARG—atherosclerosis	4.22e-06	5.82e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	4.19e-06	5.78e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—INS—atherosclerosis	4.14e-06	5.71e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	4.14e-06	5.7e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	4.13e-06	5.69e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.12e-06	5.68e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	4.07e-06	5.61e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—atherosclerosis	4.06e-06	5.6e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	4.05e-06	5.58e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.99e-06	5.5e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.98e-06	5.49e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—INS—atherosclerosis	3.9e-06	5.38e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.9e-06	5.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.9e-06	5.37e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	3.87e-06	5.34e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.87e-06	5.33e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	3.83e-06	5.28e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.82e-06	5.27e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—atherosclerosis	3.8e-06	5.24e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	3.79e-06	5.23e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	3.77e-06	5.19e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	3.76e-06	5.19e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.76e-06	5.18e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—atherosclerosis	3.76e-06	5.18e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	3.76e-06	5.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	3.75e-06	5.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.75e-06	5.17e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOB—atherosclerosis	3.73e-06	5.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	3.71e-06	5.11e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	3.69e-06	5.09e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	3.68e-06	5.07e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NOS3—atherosclerosis	3.63e-06	5.01e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.63e-06	5.01e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—atherosclerosis	3.58e-06	4.93e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LPL—atherosclerosis	3.56e-06	4.91e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	3.52e-06	4.86e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	3.49e-06	4.81e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	3.48e-06	4.8e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GPX1—atherosclerosis	3.48e-06	4.79e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	3.47e-06	4.78e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—atherosclerosis	3.47e-06	4.78e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	3.44e-06	4.75e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—atherosclerosis	3.44e-06	4.74e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	3.43e-06	4.72e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.42e-06	4.72e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	3.42e-06	4.71e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	3.41e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CD36—atherosclerosis	3.39e-06	4.67e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	3.37e-06	4.65e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—atherosclerosis	3.32e-06	4.58e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	3.29e-06	4.54e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	3.28e-06	4.53e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	3.22e-06	4.44e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.21e-06	4.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	3.19e-06	4.4e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	3.19e-06	4.39e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	3.16e-06	4.36e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.15e-06	4.34e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	3.13e-06	4.32e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.13e-06	4.32e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	3.13e-06	4.31e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AGT—atherosclerosis	3.05e-06	4.2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.99e-06	4.13e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOE—atherosclerosis	2.99e-06	4.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.96e-06	4.08e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.95e-06	4.07e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.9e-06	4e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.7e-06	3.72e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.6e-06	3.59e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—INS—atherosclerosis	2.55e-06	3.52e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.41e-06	3.33e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—atherosclerosis	2.41e-06	3.32e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.4e-06	3.31e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.36e-06	3.25e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—atherosclerosis	2.34e-06	3.23e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—atherosclerosis	2.26e-06	3.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.24e-06	3.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	2.22e-06	3.06e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—atherosclerosis	2.21e-06	3.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.19e-06	3.02e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.17e-06	3e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.05e-06	2.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	2.02e-06	2.78e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—atherosclerosis	1.67e-06	2.3e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.57e-06	2.17e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.03e-06	1.42e-05	CbGpPWpGaD
